Our Approach

Braincure has a patent-pending device that is implanted in the omentum, a protective layer of skin that protects the abdominal organs. The device is designed to stimulate the omentum in patients with Alzheimer’s Disease. Omental stimulation has been shown to improve cognitive function in patients with dementias, including Alzheimer’s Disease.

Braincure will evaluate the effect of omental stimulation at different intervals and levels of stimulation to determine the device’s ability to slow, stop or reverse the progression of Alzheimer’s Disease on patients.

 

About the Omentum

Generally described as a protective layer in the abdomen, the omentum covers the intestines, hangs on to the stomach and can be lifted like a flap. While the omentum is not a well-recognized body part, it can play important healing and protective roles for its host.

Protection: The omentum has abundant blood and lymphatic vessels, and can move flexibly throughout the abdomen to protect organs from threat and injury.

Healing: Additionally, it contains the largest supply of stem cells in the adult body. Because of its abundant blood supply, surgeons have long used the omentum to patch internal injuries sustained to other parts of the body.

 

Braincure's Technology

Patent-pending technology has allowed for the development of a medical device that can be implanted using a minimally invasive procedure. Once implanted via what will probably be a same-day surgery procedure, patients may not have to undergo surgery again using this treatment method.

 

Clinical Trials

The Company is now in the process of preparing for initial clinical trials that will most likely occur at multiple medical centers in Europe.

 

Collaboration

In addition to our in-house drug discovery programmes, we are committed to working with other organisations on a collaborative basis to maximise the impact of our own and their research and development activities.

We collaborate with other organisations to assist with their drug discovery efforts. Partners include large pharmaceutical companies, small biotech businesses and universities.